Tedizolid phosphate
Sponsors
Assistance Publique Hopitaux De Paris, Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Amit.Pai, Merck Sharp & Dohme LLC
Conditions
Acute Bacterial Skin and Skin Structure InfectionsObesityPneumoniaSkin Diseases, Bacterialfirst suspected infection with Mycobacterium tuberculosis in the lungs
Phase 1
Phase 2
Phase 3
Tedizolid Phosphate (TR-701 FA, MK-1986) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)
CompletedNCT02019420
Start: 2014-01-06End: 2018-06-22Updated: 2019-06-27
A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)
CompletedNCT03176134
Start: 2019-01-20End: 2023-07-06Updated: 2025-07-31